These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7012693)

  • 1. Enzyme-linked immunosorbent assay (ELISA) for antibodies to human myelin and axolemma-enriched fractions.
    Calabrese VP; Wallen W; Castellano G; Ward L; Anderson MG; DeVries GH
    Neurosci Lett; 1981 Jan; 21(2):189-95. PubMed ID: 7012693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisera to an axolemma-enriched fraction have antiaxon and antimyelin effects in vitro.
    Bourdette DN; Seil FJ; Meshul CK; Bigbee JW; DeVries GH; Agrawal HC
    Ann N Y Acad Sci; 1988; 540():423-6. PubMed ID: 3207273
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid alterations of the axon membrane in antibody-mediated demyelination.
    Saida K; Saida T; Kayama H; Nishitani H
    Ann Neurol; 1984 Jun; 15(6):581-9. PubMed ID: 6331280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Freeze-fracture characterization of isolated myelin and axolemma membrane fractions.
    Cullen MJ; de Vries GH; Webster HD
    Brain Res; 1981 Dec; 229(2):311-22. PubMed ID: 7306816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of an antiserum against an axolemma-enriched fraction.
    Bigbee JW; Calabrese VP; DeVries GH
    J Neuroimmunol; 1985 Jan; 7(4):221-9. PubMed ID: 2578136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and partial characterization of rat CNS axolemma enriched fractions.
    DeVries GH; Matthieu JM; Beny M; Chicheportiche R; Lazdunski M; Dolivo M
    Brain Res; 1978 May; 147(2):339-52. PubMed ID: 206316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition of axolemma-enriched fractions isolated from bovine CNS myelinated axons.
    DeVries GH; Payne W; Saul RG
    Neurochem Res; 1981 May; 6(5):521-37. PubMed ID: 7279111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid precursor protein is enriched in axolemma and periaxolemmal-myelin and associated clathrin-coated vesicles.
    Sapirstein VS; Durrie R; Berg MJ; Marks N
    J Neurosci Res; 1994 Feb; 37(3):348-58. PubMed ID: 8176757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Principles, problems, and strategies in the use of antigenic mixtures for the enzyme-linked immunosorbent assay.
    Kenny GE; Dunsmoor CL
    J Clin Microbiol; 1983 Apr; 17(4):655-65. PubMed ID: 6343423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity and cross-reactivity of antimyelin antibodies as determined by sequential adsorption analysis.
    McMillan PN; Mickey DD; Kaufman B; Day ED
    J Immunol; 1971 Dec; 107(6):1611-7. PubMed ID: 4107655
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic AMP and calcium as potential mediators of stimulation of cultured Schwann cell proliferation by axolemma-enriched and myelin-enriched membrane fractions.
    Meador-Woodruff JH; Lewis BL; DeVries GH
    Biochem Biophys Res Commun; 1984 Jul; 122(1):373-80. PubMed ID: 6331451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement-fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia.
    Latov N; Gross RB; Kastelman J; Flanagan T; Lamme S; Alkaitis DA; Olarte MR; Sherman WH; Chess L; Penn AS
    Neurology; 1981 Dec; 31(12):1530-4. PubMed ID: 7198204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of non-myelin plasma membranes unique to white matter.
    Ghosh SK; Koenig E
    Biochim Biophys Acta; 1977 Oct; 470(1):104-12. PubMed ID: 197999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antigenicity of myelin encephalitogenic protein: production of antibodies to encephalitogenic protein with deoxyribonucleic acid--encephalitogenic protein complexes.
    Whitaker JN
    J Immunol; 1975 Feb; 114(2 pt 2):823-8. PubMed ID: 46251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of reactive gliosis in vivo by exogenous axolemma and myelin fractions.
    Politis MJ
    Exp Neurol; 1988 May; 100(2):288-96. PubMed ID: 3360070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An enzyme-linked immunosorbent assay for detection of antibodies against halothane-altered hepatocyte antigens.
    Kenna JG; Neuberger J; Williams R
    J Immunol Methods; 1984 Dec; 75(1):3-14. PubMed ID: 6392423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive-beta-D-galactosidase-linked immunosorbent assay for anti-myelin basic protein antibody.
    Akiyama K
    Jpn J Exp Med; 1983 Aug; 53(4):181-5. PubMed ID: 6198541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzyme linked immunosorbent assay (ELISA) for the determination of circulating antigen and antibody in Schistosoma haematobium-infected baboons.
    Ismail MM; James C; Webbe G
    Trans R Soc Trop Med Hyg; 1981; 75(4):542-8. PubMed ID: 7034318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A micromethod for absorption of specific antibody using an enzyme-linked immunosorbent assay (ELISA).
    Calabrese VP
    J Neurosci Methods; 1984 Jun; 11(2):137-41. PubMed ID: 6207389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential proliferative responses of cultured Schwann cells to axolemma- and myelin-enriched fractions. I. Biochemical studies.
    Yoshino JE; Dinneen MP; Lewis BL; Meador-Woodruff JH; Devries GH
    J Cell Biol; 1984 Dec; 99(6):2309-13. PubMed ID: 6501427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.